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Objective: To evaluate cartilage repair tissue (RT) using MOCART scoring for morphological and T2
mapping for biochemical assessment following implantation of GelrinC, a biosynthetic, biodegradable
hydrogel implant.
Design: MR imaging (1.5/3T) was performed on 21 patients at six sites. Standard protocols were used for
MOCART evaluation at 1 week (baseline) 1, 3, 6, 12, 18 and 24 months. Multi-echo SE was used for T2
mapping. Global (T2 in RT divided by T2 in normal cartilage) and zonal T2 index (deep T2 divided by
superﬁcial T2) of RT were calculated.
Results: AverageMOCART scorewas 71.8 (95% CI 62.2 to 81.3) at six, 75.2 (95% CI 62.8 to 87.5) at twelve,
71.8 (95% CI 55.4 to 88.2) at eighteen and 84.4 (95% CI 77.7 to 91.0) at twenty-four months. The global T2
index ranged between 0.8 and 1.2 (normal healthy cartilage) in 1/11 (9%) patients at baseline, 8/12 (67%)
at 12 months, 11/13 (85%) at 18 months and 13/16 (81%) at 24 months. The zonal T2 index for RT was
<20% difference to the zonal T2 index for normal cartilage in: 6/12 patients (50%) at 12 months, 7/13
(53.8%) at 18 months and 10/16 (63.5%) at 24 months. The standard deviation for T2 showed a signiﬁcant
decrease over the study.
Conclusions: The increase of MOCART scores over follow-up indicates improving cartilage repair tissue.
Global and zonal T2 repair values at 24 months reached normal cartilage in 81% and 63.5% of the patients
respectively, reﬂecting collagen organization similar to hyaline cartilage.
© 2015 The Authors. Published by Elsevier Ltd and Osteoarthritis Research Society International. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Magnetic resonance imaging (MRI) techniques have been
widely used for the evaluation of the morphological status as well: S. Trattnig, High Field MR
ge-guided Therapy, Medical
na, Austria. Tel: 431-40-400-
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r Ltd and Osteoarthritis Research Sas for the quality of regenerated cartilage during postoperative
follow-up. However, the visualization and quantiﬁcation of the
ultrastructural composition of cartilage repair tissue (RT), specif-
ically comparing its hyaline-like vs ﬁbrous characteristics, requires
specialized MR imaging techniques.
In addition to the evaluation of gross cartilage morphology of
the RT, MR sequences such as delayed gadolinium-enhancedMRI of
cartilage (dGEMRIC) and the mapping of the transverse relaxation
time (T2 mapping) permit the assessment of key matrix compo-
nents of the tissue, speciﬁcally, dGEMRIC for glycosaminoglycan
(GAG) content and T2 mapping for water concentration and
collagen architecture and orientation1e3. While dGEMRIC requires
injection of a gadolinium contrast agent, T2 mapping is a “natural”ociety International. This is an open access article under the CC BY-NC-ND license
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free water molecules with the extracellular matrix, in particular
collagen ﬁbers and can detect differences in zonal collagen ﬁbers
orientation between healthy and damaged cartilage.
T2 relaxation time measurements deﬁne different structural
tissue characteristics of cartilage RT and enable monitoring the
maturation process4e9. In general it could be demonstrated that in
the early stages after cartilage repair surgery elevated T2 values
were reported up to 1 year, while at 1 year and later after surgery T2
values decreased to values close to normal cartilage. This was found
in patients after microfracture as well as after matrix assisted
autologous chondrocyte transplantation (MACT)8,10e15. Since
ﬁbrous tissue reduces T2 relaxation times compared to hyaline
cartilage, lower T2 values were observed in RT after microfracture
as compared toMACT RT in studies with a follow-up of more than 2
years after surgery4,10,16. In addition most studies reported that
normal zonal variation of hyaline cartilagewith lower T2 relaxation
times in the deep zone of cartilage and higher T2 relaxation times
in the superﬁcial zone due to the collagen ﬁber network with more
anisotropic collagen ﬁbers in the deep zone, was lacking in RT after
microfracture10,13,17e19.
Fibrous tissue has generally disorganized collagen ﬁbers orien-
tation with lack of zonal variation as well as reduced mobility of
water molecules leading to a decrease in T2 values. Hyaline carti-
lage is characterized by zonal organization of articular cartilage
with collagen ﬁbers running perpendicular to cortical bone in the
deep zone of cartilage. Anisotropic orientation of the collagen ﬁbers
in the deep zone affects the mobility of water molecules and thus
reduce the water proton T2 relaxation time compared to the su-
perﬁcial zone. In the superﬁcial zone, the collagen ﬁbers are ori-
ented more randomly resulting in less restricted mobility of water
molecules and thus longer T2 relaxation times. This so called zonal
variation has been reported to be a marker for collagen ﬁber or-
ganization and network in healthy hyaline cartilage10.
Surgical techniques for cartilage repair vary from tissue
debridement and bone marrow stimulation such as drilling and
microfracture (MFX), to more sophisticated cell based trans-
plantation such as autologous chondrocyte implantation (ACI) and
MACT. Despite success with cell based treatments, there is no
consensus as to the quality of the regenerated cartilage and long
term outcome of the RT20,21. These technologies are associated with
higher cost compared to MFX.
Newly available, cell-free scaffolds have the advantage of
requiring only a single surgical procedure and are typically made
from biodegradable synthetic or natural polymers. These scaffolds
provide a matrix onto which mesenchymal stem cells (MSCs)
originating from the microfractured subchondral bone attach,
differentiate and develop into RT. GelrinC (GelrinC, Regentis Bio-
materials, Or Akiva, Israel) is a new cell-free biosynthetic hydrogel
implant requiring a single procedure. GelrinC was developed to
support consistent and effective cartilage regeneration in a simple,
single-step procedure without the need for either autologous or
allogeneic cells.
GelrinC solution is composed of synthetic component e poly-
ethylene glycol diacrylate (PEG-DA), and a natural component e
denatured human ﬁbrinogen (DHF). The cured implant consists of a
continuous network of cross-linked PEG-DA that is covalently
conjugated to a backbone of denatured disulﬁde-reduced ﬁbrin-
ogen chains via its reduced thiol group.
GelrinC is provided to the surgeon as a liquid solution. Following
preparation of the defect using a standard debridement and
microfracture procedure22, GelrinC is applied to the defect in liquid
form so that it completely ﬁlls the lesion. Following 90-sec expo-
sure to UVA light, GelrinC is converted into a soft, elastomeric
implant. GelrinC implant acts as a scaffold for tissue repair bygradually eroding over time, allowing for new cartilage to take its
place and it is completely resorbed in-vivo within 6e12 months.
GelrinC is ready-to-use, cell-free implant, provided to the sur-
geon as an off-the-shelf product.
GelrinC procedure is simple, one-step e It adds about 15 min to
a standard microfracture. It is applied to the defect as liquid and
photo-cured in situ. This allows for perfect ﬁlling of the defect
regardless of its geometry, shape and depth. The resultant implant
is optimally integrated with surrounding cartilage and bone tissue.
Clinical study demonstrated that GelrinC has outstanding safety
and efﬁcacy outcome and new hyaline-like cartilage is formed from
the periphery of the defect towards the center. GelrinC, by pre-
senting a gradually receding surface to the surrounding tissue, al-
lows incoming cells to adhere to the implant matrix and for the
regeneration process to proceed. As a result, as the implant de-
grades on its surface, primarily through the action of proteases
secreted by attached cells, new hyaline-like cartilage is formed
from the periphery of the defect towards the center.
The aim of this multi-center single arm study was to assess the
quality of RT of patients after GelrinC implantation in the femoral
condyle. Quality was evaluated using clinical outcome, morpho-
logical appearance and quantitative T2 values using MRI.
Method
Institutional review board approval was obtained from all
participating medical centres. The study included screening eval-
uation for eligibility, diagnostic arthroscopy and surgery as well as
follow-up of clinical and radiological (MRI) evaluations, rehabili-
tation program, adverse events, concomitant medication and sub-
sequent interventions. All patients signed an informed consent
before participating in the study.
Patient population
Twenty-one (5 females and 16 males, mean age 36 ± 10 years;
age range 18÷51) patients were treated with GelrinC in the period
between 2009 and 2012. All patients were treated for a single full
thickness cartilage defect.
Inclusion and exclusion criteria
Inclusion criteria included patients with one or two contained
symptomatic lesion/s to the femoral condyle, lesion size between 1
and 6 cm2 with a maximal diameter of 2.5 cm and with less than
6mm into the subchondral bone. Body mass index (BMI)32, knee
should be stable and previous or concurrent meniscus resection of
nomore than 50%. Excludedwere patients younger than 18 years or
older than 65 years, with lesions greater than 6 cm2 or smaller than
1 cm2, lesions to the patella or trochlea, patients with diffuse
degenerative joint disease and those who had contraindications to
perform MRI (i.e., patients with pacemakers, claustrophobia, etc).
Procedure
GelrinC was implanted in a single procedure following standard
MFX treatment. The patient was prepared for surgery, anaes-
thetized and a tourniquet applied. The lesion was debrided of any
cartilage fragments and the calciﬁed layer was completely removed
before standardMFXwas performed. The lesionwas then evaluated
for eligibility. If eligible, GelrinC liquidwas applied to completely ﬁll
the defect. A GelrinC accessory kit was used to seal the defect and
facilitate injection of GelrinC in non-horizontal positioned lesions.
Using a light guide, the implant was exposed to ultraviolet light for
90 s to cure the GelrinC hydrogel into a soft, elastomeric implant.
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inspected for completeness. The joint was then ﬂexed to ensure
that the implant was secured in the lesion. To complete the pro-
cedure, the joint capsule and surrounding tissue were closed in
standard fashion. The GelrinC implant naturally degrades in syn-
chronization with the growth of cartilage RT within 6e12 months.
Clinical evaluation
For assessment of the clinical outcome, Overall KOOS, individual
KOOS subscales and International Knee Documentation Committee
(IKDC) scores were used.
Image acquisition
Each subject underwent several MR examinations in pre-deﬁned
intervals after surgery: 1 week (baseline), 1, 3, 6, 12, 18 and 24
months. According to protocol design, MRI scan for 1 and 3 months
were performed only on the ﬁrst 6 patients. All MR examinations
were performed at six sites in Europe and Israel using a standard-
ized examination protocol on a 1.5 or 3T MR scanner (Siemens
Healthcare, Philips or GE Healthcare) using a gradient strength of
40 mT/m and dedicated knee coils (mostly using an 8-channel
phased array knee coil). All MRIs acquired on the same individual
were performed on the same scanner, using the same coil. Special
attention was paid to ensure that the patients were positioned
consistently with the knee extended and minimally externally
rotated in the coil to minimize potential magic angle effects. For
morphologic evaluation, the following sequences were performed
at all sites and with all MR scanners to enable a semi-quantitative
morphological scoring based on the MOCART scoring system23.
Sagittal T1-SE for scoring of bone changes in MOCART score,
sagittal proton density (PD) FSE, coronal PD-FSE with fat-
saturation, 3D gradient recalled echo (GRE) sequences (not avail-
able at all sites) with parameters adapted according to MR vendor,
scanner type and coil used. The basic measurement parameters are
listed in Table I.
The T2 relaxation times were obtained from T2 maps recon-
structed using a CPMG multi-echo spin-echo technique with a
repetition time (TR) of 2640 ms. Eight echo times (TE) in the range
of 12.5e87.5 ms were collected. Images were acquired in the
sagittal plane for the femoro-tibial compartments. Main measure-
ment parameters were as follows: slice thickness of 3 mm, number
of slices 15, FOV of 160 160 mm2, matrix size 256 225 pixels, fat
suppression was not applied, time of acquisition was 5 m 10 s.
MRI evaluation
The MOCART scoring system23 was used for MRI morphological
evaluation. This point-scoring system was designed toTable I
Basic imaging parameters of all sequences are listed
Orient. Contrast Sl.thick [mm] Fatsat TR [ms] TE [ms] No
3.0 T
sag PD þ T2 2 no 3050 11 þ 80
sag PD 2 mm 2 no 2000 37
cor PD fs 3 yes 2970 27
sag T1 se 2 no 680 12
sag T2 map 3 no 2640 12.5e87.5
1.5 T
sag PD þ T2 2 no 3480 13 þ 94
sag PD 2 mm 2 no 2000 27
cor PD fs 3 yes 3430 31
sag T1 se 2 no 600 13
PD fs, proton density fat suppressed; T1 se, T1 spin echo.systematically record the constitution of the area of cartilage repair
and surrounding tissues, and has been shown to be reliable and
reproducible and can be applied to different surgical cartilage
repair techniques24,25. The maximum score achievable in the
evaluation of nine variables is 100, except in cases when
GRE images were not provided resulting in a maximum possible
MOCART score of 85. In such cases, a correction factor of a 100/
85 ¼ 1.176 was applied. In practice, if the total MOCART score
without GRE was evaluated for example as 85, a correction was
performed by multiplying 85 by the correction factor 1.176 for a
total of 99.96 (rounded to 100.0).
Special emphasis was placed on the variables “degree of defect
repair and ﬁlling of the defect” and “signal intensity” of the MOCART
score,which represents degree ofmaturation of the RTover time23,26.
The baseline score (1 week post-surgery) on the point scale of
the MOCART score was judged to be “0”. This was based on the fact
that at 1 week post-surgery, GelrinC implant displays ﬂuid-like
signal intensity on MR indicating that the lesion is completely ﬁl-
led and presenting “false” high scores. In addition, 1 week after
surgery theMFX procedure displays subchondral bone changes, the
subchondral lamina is perforated and effusion is present.
All MRI images were evaluated for total MOCART scoring sepa-
rately by two experienced senior musculoskeletal radiologists (one
with 24 and the other with 6 years of experience inmusculoskeletal
MR). Any disagreements were discussed and a consensus was
reached. Reviewers were blinded to the patient's clinical history
and the location of the lesion (medial or lateral femoral condyle).
The assessment of the T2 values, based on a region-of-interest
(ROI) evaluation, was performed by a single reviewer, which has
an experience of 24 years in MSKMR imaging. The average number
of pixels on the RT and on the reference normal tissue was 14 ± 5
and 13 ± 4, respectively. On the same condyle, an area of RT and an
area of healthy cartilage at least 1 cm in distance from the RT (as an
internal control) were selected using the morphologic MRI dataset.
The selection of the ROIs was made on 1 to 4 consecutive slices
depending on the size of cartilage repair. In cases where there was
more than one slice used, the T2 values were averaged. The ROIs for
cartilage RTand healthy hyaline cartilagewere selected to cover the
full thickness of the cartilage layer. For the purpose of zonal vari-
ation assessment, these ROIs were divided equally into a deep and a
superﬁcial half. T2 maps were calculated using a pixel-wise, mono-
exponential, non-negative least-squares (NNLS) ﬁt analysis (IDL
6.3, Interactive Data Language, RSI, Inc., Boulder, CO, USA). The in-
dividual T2 index, which is a dimensionless coefﬁcient, was
calculated by expressing global mean T2 of the RT relative to global
mean T2 of healthy cartilage. For the zonal variation, a “zonal T2
index”was calculated as a T2 relaxation times of the RT in the deep
zone divided by the T2 relaxation times of the RT in the superﬁcial
zone. To our best knowledge, this is ﬁrst time when the T2 zonal
variation index was calculated, in order to eliminate differences in. of slices FOV [mm] Matrix Phase- res. (%) Scan time (min:sec)
19 160 448 80 3:17
19 120 384 85 3:20
25 160 448 80 3:29
19 160 384 100 2:50
15 160 256 88 5:10
19 160 384 90 4:16
19 120 320 90 4:24
25 160 384 100 4:36
19 160 384 100 4:09
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character of our study. The same calculation of the zonal T2 index
was performed for normal healthy cartilage. The absolute global T2
values were only used for the analysis of longitudinal development
of the standard deviation of T2 relaxation times.
Data and statistical analysis
Comparison of data from each visit to 6 months time point was
performed using a paired t-test for MOCART score as well as T2
index at the different time points. Furthermore, Spearman corre-
lation coefﬁcient was used for evaluating possible correlation be-
tween each of the different calculated parameters (MOCART
morphological scores, the biochemical zonal T2 index values for
both RT and reference native cartilage) and clinical outcome with
time after implantation, with the age of the patient and with each
other. Correlation of the above parameters with the lesion size (pre-
and post-debridement) was also performed. All statistical calcula-
tions were performed by using statistical software (SPSS version 21,
SPSS, Chicago, Ill, USA).
Results
Patient follow-up, implant size and location
Nineteen patients completed 12 months follow-up, 19 patients
completed 18 months follow-up and 18 patients completed 24
months follow-up. Analysis was performed on 17 patients at 24
months, 14 patients at 18 months and 19 patients at 12 months
where MRI images were available. The GelrinC implant was located
on the medial femoral condyle in 17 patients (81%) and on the
lateral femoral condyle in 4 patients (19%). The mean implant area
was 2.54 ± 1.12 cm2 (range: 1÷5 cm2). Six patients had an implant
area smaller than 2 cm2 (mean: 1.41 ± 0.34 cm2, range: 1÷1.8 cm2)
and 13 patients had an implant area of 2 cm2 and above (mean:
2.99 ± 0.99 cm2, range: 2÷5 cm2). Two patients did not have
documentation of the implanted area.
Morphological evaluation
The mean global MOCART scoring improvement from baseline
of the RT is shown in Table II with an increase of the total MOCART
at all time points and maximummean score up to 84.4 points (95%
CI 77.7 to 91.0) at 24 months. From 6 months to 12 months, though
there was an increase of MOCART score from 71.8 (95% CI 62.2 to
81.3) to 75.2 (95% CI 62.8 to 87.5) it was not statistically signiﬁcant
(N ¼ 18, P ¼ 0.308), however, changes from 6 to 24 months were
statistically signiﬁcant with an increase of the MOCART score from
71.8 (95% CI 62.2 to 81.3) at 6 months to 84.4 (95% CI 77.7. to 91.0)
(N¼ 17, P< 0.005). Fig.1 shows an example of follow-up of a patient
at 1 week, 6, 12 and 24 months post-surgery. In six analyses of the
MOCART score a disagreement between readers was discussed and
a consensus was reached.Table II
Descriptive Statistics for MOCART, changes from baseline
Visit
Mean Min Median
1 Month Follow-Up 61.8 47.0 65.0
3 Months Follow-Up 63.7 41.0 65.0
6 Months Follow-Up 71.8 6.0 73.5
12 Months Follow-Up 75.2 6.0 82.0
18 Months Follow-Up 71.8 6.0 79.0
24 Months Follow-Up 84.4 53.0 88.0The variable “signal intensity” of the MOCART score showed an
increase from 9.3 points at 6 month (N ¼ 20, 95% CI 6.7 to 11.8) to
14.4 points (maximum 15 points) at 24 months (N ¼ 17, 95% CI 13.2
to 15.7) and thus nearly reaching the maximum value compared to
normal, healthy cartilage (Table III).
Evaluation of the global T2 index
The mean T2 index showed a decrease over time for global
cartilage of 2.5 (95% CI 1.8 to 3.3, N¼ 11); superﬁcial cartilage zone:
2.1 (95% CI 1.6 to 2.7, N ¼ 13); deep cartilage zone: 2.8 (95% CI 2.2 to
3.4, N ¼ 13) at baseline (1 week after surgery) and mean T2 index
for global cartilage of 1.3 (95% CI 1.1 to 1.5, N ¼ 16); superﬁcial
cartilage zone: 1.2 (95% CI 1.0 to 1.4, N ¼ 16); deep cartilage zone:
1.3 (95% CI 1.1 to 1.5, N ¼ 16) at 24 months follow-up (Table IV).
The global T2 index at baseline were found to be between 0.8
and 1.2 (what is considered normal healthy cartilage) in 1/11 (9%) of
patient at baseline, in 8/12 (67%) of patients at 12 months, in 11/13
(85%) of patients at 18 months and in 13/16 (81%) of patients at 24
months (Fig. 2).
Evaluation of the zonal T2 index
The zonal T2 index for the RT was found to be close (less than
20% difference) to the zonal T2 index of normal cartilage in 6/12
patients (50%) at 12 months, in 7/13 (53.8%) patients at 18 months
and in 10/16 (63.5%) patients at 24 months, with 7 of 10 patients
showing a difference of the zonal T2 index of less than 10% at 24
months. An example of T2 zonal evaluation is shown on Fig. 3.
Superﬁcial and deep ROIs for cartilage transplant tissue and normal
healthy cartilage are shown.
Longitudinal development of standard deviation of global T2 in RT
and normal cartilage
The standard deviation of global T2 among pixels in the evalu-
ated ROIs in RT was decreasing over time (Fig. 4). An initial (early
post-surgery) standard deviation of global T2 showed an average of
49.4. Later post-surgery standard deviations of global T2 in evalu-
ated ROIs at 12, 18 and 24 months reached in average 17.3, 15.6 and
17.0, respectively. For a reference, the standard deviation of global
T2 in ROIs drawn in the normal hyaline cartilage was evaluated to
be 12.9.
Correlation between T2 mapping and the MOCART score
Considering different variables of the MOCART score, a negative
correlation was found between T2 values and the degree of defect
repair (r ¼ 0.62, P ¼ 0.01) at the 24 months follow-up. A high
negative correlation was also found between T2 values and the
integration with the border zone (r ¼ 0.75, P < 0.01) and the
surface of the RT (r ¼ 0.70, P < 0.01) at 24 months. Total MOCART
score also showed negative correlation with T2 values (r ¼ 0.62,Difference from baseline
Max 95% Lower CL 95% Upper CL N
76.0 49.0 74.6 6
76.0 49.5 77.9 6
94.0 62.2 81.3 20
100.0 62.8 87.5 19
100.0 55.4 88.2 14
100.0 77.7 91.0 17
Fig. 1. Series of proton density fat suppressed images in coronal plane show development of cartilage transplant in follow-up examinations. Arrows and circle delineate RT area.
Table III
Descriptive Statistics of signal intensity of the repair tissue (Dual FSE) in MOCART
Visit Signal intensity of the repair tissue
Mean Min Median Max 95% Lower CL 95% Upper CL N
1 Month Follow-Up 1.7 0.0 0.0 5.0 0.0 4.4 6
3 Months Follow-Up 3.3 0.0 5.0 5.0 0.6 6.0 6
6 Months Follow-Up 9.3 0.0 5.0 15.0 6.7 11.8 20
12 Months Follow-Up 11.1 0.0 15.0 15.0 8.1 14.0 19
18 Months Follow-Up 12.1 0.0 15.0 15.0 8.8 15.5 14
24 Months Follow-Up 14.4 5.0 15.0 15.0 13.2 15.7 17
Table IV
Descriptive Statistics of T2 mapping e effectiveness population
T2 Parameter/Visit Mean Min Median Max 95% Lower CL 95% Upper CL N
Deep 1 Week Follow-Up 2.8 1.2 2.9 4.4 2.2 3.4 13
12 Months Follow-Up 1.1 0.8 1.1 1.6 0.9 1.3 12
18 Months Follow-Up 1.3 0.8 1.0 4.9 1.1 1.5 13
24 Months Follow-Up 1.3 0.6 1.0 5.4 1.1 1.5 16
Global 1 Week Follow-Up 2.5 0.9 2.3 4.9 1.8 3.3 11
12 Months Follow-Up 1.1 0.9 1.1 1.3 1 1.2 12
18 Months Follow-Up 1.2 0.8 0.9 4.2 1.1 1.4 13
24 Months Follow-Up 1.3 0.7 1.0 5.1 1.1 1.5 16
Superﬁcial 1 Week Follow-Up 2.1 1.0 1.9 4.5 1.6 2.7 13
12 Months Follow-Up 1.2 0.8 1.2 1.5 1.1 1.3 12
18 Months Follow-Up 1.2 0.8 1.0 3.5 0.9 1.5 13
24 Months Follow-Up 1.2 0.6 1.0 4.0 1 1.4 16
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Fig. 2. T2 index development at 12, 18 and 24 months after surgery using an early
post-surgery (1 week) measurement as a reference. A 95% CI as a measure of uncer-
tainty is indicated.
Fig. 3. An example of T2 zonal evaluation. Superﬁcial and deep ROIs for cartilage
transplant tissue (posterior aspect on the image) and normal healthy cartilage (ante-
rior aspect of the image) are shown.
Fig. 4. Change of T2-standard deviations among the pixels of the ROIs drawn on the RT in
reference a standard deviation of healthy tissue was used.
S. Trattnig et al. / Osteoarthritis and Cartilage 23 (2015) 2224e2232 2229P ¼ 0.01) at 24 months. Image examples of morphological and T2
mapping of the post-surgery period are shown in Fig. 5. Cartilage in
T2 maps is pseudo-colored for better visualization.
Discussion
In this prospective, single arm, longitudinalmulticentre study the
safety and efﬁcacy of a new GelrinC cartilage repair procedure in
patients at different time intervals post-surgery (1week,1, 3, 6,12,18
and 24 months) were evaluated. Patients were evaluated for clinical
outcome, morphological and biochemical properties using MRI.
Morphological MRI evaluation
Twenty-four months after the surgery, a MOCART score of 84.4
was achieved. Signiﬁcant differences in the MOCART scores in the
entire cohort were found when comparing cartilage implant be-
tween 6 and 24 months. These ﬁndings are different from results
seen in other studies following MACT procedure at early post-
operative follow-up (3 months) and at 12 months follow-up
period4,11 and in patients after MFX procedure27 in which the
MOCART score did not signiﬁcantly change at different time in-
tervals. For the “degree of defect repair and ﬁlling of the defect”, the
values achieved already after 6 months post-surgery did not
signiﬁcantly change over the next 18 months, which may be
explained by the nature of the GelrinC procedure with a tightly
ﬁxed soft, elastomeric implant ﬁlling the defect completely starting
at the surgery. A steady improvement in “signal intensity” was
observed from 6 to 24 months and a near complete normalization
of the RT signal intensity is reported at 24months. This corresponds
to a morphologically excellent maturation process of the tissue.
Only low positive correlation was found between the MOCART
score and the clinical outcome KOOS Sport Score at 24 months
follow-up. This is consistent with a similar ﬁnding reported by Buda
et al.28 where a high correlation between KOOS and the MOCART
“signal intensity” score was found.
T2 mapping results
It has been previously demonstrated that ﬁbrous RT shows
lower T2 relaxation times (which corresponds to T2 index < 1) than
normal hyaline cartilage16. Correspondingly, lower T2 values were
observed in RT after MFX as compared to MACT RT, while no dif-
ferences in Lysholm or MOCART scores were detected10,27,29. Oneto
et al. initially found elevated T2 values (corresponding to a T2post-surgery period. The numbers in brackets indicate number of ROIs included. As a
Fig. 5. Image examples of morphological (left column) and T2 mapping (right column)
of the post-surgery period are shown. Cartilage in T2 maps is pseudo-colored for better
visualization. Color-bar is added for T2 map quantiﬁcation.
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after 2 years in cases of good graft maturation and lower T2 values
for therapy failure12. Theologis et al. reported that 3e6months after
surgery MFX RT had signiﬁcantly higher T1rho and T2 values
relative to normal cartilage9. At 1 year, T2 values of RT decreased to
reach values comparable to normal cartilage (T1rho remained
signiﬁcantly different). Welsh et al. detected in two different
studies reduced T2 values in cartilage repair area after MFX,
whereas, after MACT, T2 similar to normal cartilage was observed
between 2.3 and 2.7 years after surgery10,27. Most studies howeverreported that normal zonal variation was lacking after
MFX10,13,16,18,19. Tissue maturation processes can also be depicted
after ACI16. Kurkijarvi et al. showed that T2 values for RT after ACI
were higher and more heterogeneous than T2 of normal control
cartilage about 1 year after surgery with a lack of zonal organiza-
tion30. T2 relaxation times were higher for RT than for normal
cartilage at 3e13months after ACI, but no signiﬁcant differencewas
detected at later time points in several studies (after 19e42, 12e59,
and 20 months)4,10,13,14. However, T2 relaxation times of RT after
MACT generally decreased during longer postoperative in-
tervals10,13,31. According to Salzmann et al. RT had signiﬁcantly
lower T2 values than normal cartilage about 3.5 years after MACT15.
In an international, multicentre, randomized controlled trial, BST-
CarGel treatment was evaluated and compared with MFX alone
in the repair of cartilage lesions in the knee joint32. The repair
cartilage T2 relaxation times for the BST-CarGel treatment group
were signiﬁcantly different and lower than that of the MFX treat-
ment group, albeit not yet at the level of native cartilage after only
12 months and no information on zonal variation of T2 mapping
within the RT was given.
In the GelrinC study, the T2 index results are in accordance with
these published ﬁndings of absolute T2 relaxation times mentioned
above and show T2 index values from 0.8 to 1.2 for the majority of
RT after 12 months. At 24 months, values are similar to healthy,
native hyaline cartilage.
Using the T2 index calculation, Domayer et al.,29 found a cor-
relation between the Lysholm score and the IKDC subjective knee
evaluation form and the T2 index in patients after MFX and Sal-
zmann et al.15 found a correlation between the Lysholm score and
T2 mapping in patients after MACT.
Using the zonal T2 index in the current study, zonal variation in
the implanted area was clearly detected at 12e24 months after
surgery with T2 index of RT close to T2 index of normal healthy
cartilage in the majority of patients. Our new approach of calcu-
lating the zonal T2 index allows us also to avoid the problems
mentioned above regarding absolute T2 values. Zonal differences
between the different cartilage layers have previously been re-
ported10,16,33,34. However, these zonal differences seem to vary
during the maturation process after ACI. Whereas after 12 months,
no zonal stratiﬁcation was detected30, in this study zonal variation
was obvious already at 12months in themajority of our patients. At
later time points, during the second year after MACT, T2 zonal or-
ganization approached that of control healthy cartilage and per-
sisted during the period, which nicely corresponds with our results
as opposed to the lack of zonal variation described after
MFX4,10,13,14,35.
The new calculation of the mean standard deviation of T2
relaxation time over time provides additional information on the
tissue organization, since higher standard deviation means higher
heterogeneity of the RT and vice versa. In our study, the standard
deviation of the T2 relaxation time measurements decreased with
the longer follow-up periods up to 24 months signiﬁcantly and
came close to values of normal hyaline cartilage.
Overall, these ﬁndings for T2 relaxation time measurements of
cartilage RT may correspond to the described histological differ-
ences of the tissue and indicate maturation of both layers with a
decrease in water content and an increase of collagen content and
orientation27.
Limitations of the study include a rather small number of pa-
tients. However, to recruit patients for a longitudinal study which
comprises at least 4 follow-up examinations and considers all in-
clusion and exclusion criteria severely reduced the number of
available patients. Another limitation of this longitudinal study is
the restriction of time interval after surgery to 24 months. Further
development of the RT after GelrinC beyond 24 months will be
S. Trattnig et al. / Osteoarthritis and Cartilage 23 (2015) 2224e2232 2231reported in next study. This was a single arm study and comparison
with a second arm, such as microfracture or other cartilage repair
procedures would be beneﬁcial in future studies. The main purpose
of this study was evaluation of radiological outcome.
The in-plane resolution used in this studywas a limitation for T2
mapping. However, it was given by the selected matrix size. In case
a higher matrix size would have been selected the SNR would drop
and consequently the uncertainty of T2 values would increase. The
overall quality of T2 evaluation depends on the experience of per-
son drawing ROIs. Unfortunately, there is not an alternative so far
and evaluator experience is crucial in study like this one. The lack of
histological control data in this study is another limitation, how-
ever the dedicated histological large animal model study to eval-
uate safety, performance and degradation proﬁle of GelrinC in-vivo
was already performed (not published yet - currently under the
revisions).
In conclusion, signiﬁcant improvement can be expected already
1 year after GelrinC implantation. This is supported by a relatively
high mean MOCART score and the results of T2 relaxation times
calculation with T2 index, new zonal T2 index and standard devi-
ation of T2 over time, which in most cases, were comparable to
values from normal hyaline cartilage.
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